Article Details

Johnson & Johnson's IMAAVY Gets FDA Approval, Taking on Top Players in Myasthenia ...

Retrieved on: 2025-05-22 21:50:43

Tags for this article:

Click the tags to see associated articles and topics

Johnson & Johnson's IMAAVY Gets FDA Approval, Taking on Top Players in Myasthenia .... View article details on hiswai:

Excerpt

... monoclonal antibodies SOLIRIS and ULTOMIRIS. J&J will also be competing with Argenx's VYVGART and UCB's RYSTIGGO and ZILBRYSQ. LAS VEGAS, May 22 ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo